Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

FTSE 100 pulled down by miners, glum retail sales data

08/25/2020 | 03:57am EST

(For a live blog on European stocks, type LIVE/ in an Eikon news window)

* UK retailers cut jobs by most since 2009 - CBI

* Tech firm Aveva jumps on signing $5 bln takeover deal

* AstraZeneca rises on launching COVID-19 treatment trial

* FTSE 100 down 1.1%, FTSE 250 down 0.6%

Aug 25 (Reuters) - The export-laden FTSE 100 index closed lower on Tuesday, weighed down by miners and a stronger pound, while an unexpected drop in retail sales kept risk sentiment at bay.

The blue-chip London index fell 1.1% and the mid-cap FTSE 250 dropped 0.6%, abandoning gains made on optimism from a pledge by Washington and Beijing to stand by their Phase-1 trade pact.

Oil & gas companies and miners were among the top decliners by the closing bell.

British retailers have cut the most jobs since the depths of the financial crisis and expect the pace of losses to accelerate, the Confederation of British Industry said.

Sterling gained despite the monthly retail sales balance unexpectedly falling to -6 in August from July's 15-month high of +4.

The FTSE 100 is still on course for its best month since April 2018 even as concerns linger about a choppy economic recovery after a record contraction in the second quarter.

Investors are awaiting U.S. Federal Reserve Chair Jerome Powell's address at the Kansas City Fed's annual conference on Thursday for any hints as to the central bank's efforts to revamp its approach to monetary policy.

"The fact the strong start to the trading session couldn't be sustained points to an absence of conviction on traders' part. It feels like many market participants are sitting on their hands ahead of the Jackson Hole Symposium," said David Madden, market analyst at CMC Markets.

AstraZeneca Plc rose 0.1% after launching a trial for an antibody-based treatment for COVID-19.

Aveva Group rose 7.3% as it said it would buy OSIsoft, a privately held maker of industrial software used to manage plants and factories, for an enterprise value of $5 billion.

Retailer DFS Furniture Plc jumped 10.7% after saying its performance over the last six weeks was significantly above its initial expectations. (Reporting by Sagarika Jaisinghani and Shreyashi Sanyal in Bengaluru; Editing by Subhranshu Sahu and Bernadette Baum)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -1.36% 7877 Delayed Quote.5.17%
AVEVA GROUP PLC -20.19% 3267 Delayed Quote.-11.60%
CMC MARKETS PLC -2.73% 417 Delayed Quote.187.86%
DFS FURNITURE PLC -0.40% 233.055 Delayed Quote.-19.03%
LONDON BRENT OIL 0.33% 48.2 Delayed Quote.-30.61%
MSCI UNITED KINGDOM (STRD, UHD) 2.05% 1007.138 Real-time Quote.-17.10%
WTI 0.69% 45.18 Delayed Quote.-29.68%
All news about ASTRAZENECA PLC
06:06aEXPLAINER : When and how will COVID-19 vaccines become available?
RE
05:45aDow's Rise to 30000 Heralds a Broader Stock Rally
DJ
04:40aASTRAZENECA : Lokelma label update approved in China for patients with hyperkala..
AQ
02:37aFLIRTING WITH RECORD HIGHS : European stocks back to normal in 2021 - Reuters po..
RE
01:16aNEWS HIGHLIGHTS : Top Company News of the Day
DJ
11/24ANALYSIS : Dow cracks 30,000, a psychological boost during a pandemic
RE
11/24Copper near 7-year high on Biden transition, vaccine hopes, low China stocks
RE
11/24NEWS HIGHLIGHTS : Top Company News of the Day
DJ
11/24Oil closes at highest level since March on vaccine trials, Biden transition
RE
11/24Dow Jones Industrial Average Crosses 30000 for First Time
DJ
More news
Financials (USD)
Sales 2020 26 523 M - -
Net income 2020 3 016 M - -
Net Debt 2020 13 181 M - -
P/E ratio 2020 47,9x
Yield 2020 2,63%
Capitalization 140 B 140 B -
EV / Sales 2020 5,79x
EV / Sales 2021 5,04x
Nbr of Employees 70 600
Free-Float 95,7%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 121,48 $
Last Close Price 106,90 $
Spread / Highest target 45,4%
Spread / Average Target 13,6%
Spread / Lowest Target -38,3%
EPS Revisions
Managers
NameTitle
Pascal Soriot Chief Executive Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Pam P. Cheng Executive VP-Operations & Information Technology
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC5.17%140 189
JOHNSON & JOHNSON-1.37%378 744
ROCHE HOLDING AG-4.28%281 946
PFIZER INC.-6.59%203 437
MERCK & CO., INC.-11.89%202 757
NOVARTIS AG-12.66%200 273